Trial Profile
A Randomized, Double-Blind, Crossover Study to Determine the Effect of Actimmune Dose Titration on the Severity and Incidence of Interferon Gamma-1b-Related Flu-Like Symptoms and the Pattern of Dropouts in Healthy Volunteers.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 May 2015
Price :
$35
*
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Chronic granulomatous disease; Friedreich's ataxia; Osteopetrosis
- Focus Adverse reactions
- 08 May 2015 New trial record